Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
CervoMed Inc.
CRVOCurrent price
10.92 USD
-0.54 USD (-4.71%)
Last closed
11.83 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
103 501 896 USD
Yield for 12 month
+10.41 %
1Y
3Y
5Y
10Y
15Y
CRVO
CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, frontotemporal dementia, and ischemic stroke recovery. The company also develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts. Address: 20 Park Plaza, Boston, MA, United States, 02116
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
57.6 USDP/E ratio
5.4286Dividend Yield
–Current Year
+7 144 872 USD
Last Year
–
Current Quarter
+3 288 971 USD
Last Quarter
+2 347 250 USD
Current Year
-1 293 627 USD
Last Year
-1 336 469 USD
Current Quarter
+3 288 971 USD
Last Quarter
-467 008 USD
Key Figures CRVO
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
5.4286
Return On Assets TTM
-90.48 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
57.6 USD
Revenue TTM
9 653 281 USD
Book Value
6.06 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
91.2 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
2.31 USD
Diluted Eps TTM
2.31 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-52.24 %
Dividend Analytics CRVO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CRVO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
2:3
Payout Ratio
–
Last Split Date
17.08.2023
Dividend Date
14.12.2018
Stock Valuation CRVO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
5.4286
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
10.7219
Enterprise Value EBITDA
1.6373
Price Book MRQ
2.071
Financials CRVO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CRVO
For 52 weeks
5.85 USD
26.38 USD
50 Day MA
14.4 USD
Shares Short Prior Month
1 180 081
200 Day MA
17.07 USD
Short Ratio
14.46
Shares Short
1 269 645
Short Percent
23.73 %
BeatStart